ES463974A1 - Un procedimiento para la preparacion de nuevos derivados delacido clavulanico. - Google Patents

Un procedimiento para la preparacion de nuevos derivados delacido clavulanico.

Info

Publication number
ES463974A1
ES463974A1 ES463974A ES463974A ES463974A1 ES 463974 A1 ES463974 A1 ES 463974A1 ES 463974 A ES463974 A ES 463974A ES 463974 A ES463974 A ES 463974A ES 463974 A1 ES463974 A1 ES 463974A1
Authority
ES
Spain
Prior art keywords
carbon atoms
deoxyclavulanates
amino
manufacture
inert organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES463974A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES463974A1 publication Critical patent/ES463974A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Un procedimiento para la preparación de nuevos derivados del ácido clavulánico de fórmula (II) **(Fórmula)** y sales del mismo donde R1 es un grupo orgánico inerte de hasta 14 átomos de carbono y R2 es un grupo orgánico inerte de hasta 16 átomos de carbono, cuyo procedimiento consiste en desesterificar un éster del compuesto de fórmula II.
ES463974A 1975-10-13 1977-11-08 Un procedimiento para la preparacion de nuevos derivados delacido clavulanico. Expired ES463974A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB41887/75A GB1566706A (en) 1975-10-13 1975-10-13 Clavulanic acid derivatives

Publications (1)

Publication Number Publication Date
ES463974A1 true ES463974A1 (es) 1978-12-16

Family

ID=10421810

Family Applications (2)

Application Number Title Priority Date Filing Date
ES452361A Expired ES452361A1 (es) 1975-10-13 1976-10-13 Un procedimiento para la preparacion de nuevos derivados delacido clavulanico.
ES463974A Expired ES463974A1 (es) 1975-10-13 1977-11-08 Un procedimiento para la preparacion de nuevos derivados delacido clavulanico.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES452361A Expired ES452361A1 (es) 1975-10-13 1976-10-13 Un procedimiento para la preparacion de nuevos derivados delacido clavulanico.

Country Status (28)

Country Link
US (3) US4256638A (es)
JP (1) JPS5248686A (es)
AR (1) AR213294A1 (es)
AT (1) AT352874B (es)
AU (1) AU503489B2 (es)
BE (1) BE847044A (es)
CA (1) CA1094563A (es)
CH (2) CH634323A5 (es)
DD (1) DD126929A5 (es)
DE (1) DE2646003A1 (es)
DK (1) DK457676A (es)
ES (2) ES452361A1 (es)
FI (1) FI762895A (es)
FR (1) FR2327775A1 (es)
GB (1) GB1566706A (es)
GR (1) GR61674B (es)
HU (1) HU175046B (es)
IE (1) IE43840B1 (es)
IL (1) IL50618A (es)
MX (1) MX4688E (es)
NL (1) NL7611206A (es)
NO (3) NO763472L (es)
NZ (1) NZ182190A (es)
PT (1) PT65707B (es)
SE (3) SE7611047L (es)
SU (1) SU639454A3 (es)
ZA (1) ZA765901B (es)
ZM (1) ZM12276A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1091113B (it) * 1976-10-25 1985-06-26 Glaxo Lab Ltd Composizioni terapeutiche a base di n-acil-derivati di acido clavulanico e procedimento per produrle
GB1604822A (en) * 1977-04-22 1981-12-16 Beecham Group Ltd N-monosubstituted-9-amino-9-deoxyclavulanic acid derivative
US4359473A (en) 1977-04-22 1982-11-16 Beecham Group Limited α-Amino deoxy clavulanic acid antibacterial agents
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
EP0005014A1 (en) * 1978-04-22 1979-10-31 Beecham Group Plc Clavulanic acid derivatives, preparation and compositions
DE2963534D1 (en) * 1978-07-29 1982-10-07 Beecham Group Plc Clavulanic acid derivatives, a process for their preparation, their use, and pharmaceutical compositions containing them
DE2966065D1 (en) * 1978-09-09 1983-09-22 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and their compositions
ATE5143T1 (de) * 1978-09-09 1983-11-15 Beecham Group Plc Clavulansaeure-derivate und verfahren zu ihrer herstellung.
DE2966349D1 (en) * 1978-09-09 1983-12-01 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and their use
EP0010369B1 (en) * 1978-10-25 1983-07-20 Beecham Group Plc Clavulanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them
IL60343A0 (en) * 1979-07-02 1980-09-16 Beecham Group Ltd Clavulanic acid derivatives,their preparation and pharmaceutical compositions containing them
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
EP0028083B1 (en) * 1979-10-26 1984-02-08 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and pharmaceutical compositions containing them
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
JPS57143194A (en) * 1981-02-27 1982-09-04 Matsushita Electric Ind Co Ltd Blower
EP0062407A1 (en) * 1981-03-10 1982-10-13 Beecham Group Plc Therapeutic compounds containing beta-lactams
JPH0495698U (es) * 1991-01-21 1992-08-19
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1424186A (en) * 1971-10-08 1976-02-11 Beecham Group Ltd Penicillins
US3925363A (en) * 1974-01-17 1975-12-09 Merck & Co Inc Process for epimerizing penicillin compounds, and related products
US4051132A (en) * 1974-01-23 1977-09-27 Merck & Co., Inc. Process for epimerizing beta-lactam antibiotic compounds by means of an acid quench
GB1585165A (en) * 1976-06-29 1981-02-25 Leo Pharm Prod Ltd Derivatives of 6-amidino penicillanic acid
IL54859A (en) * 1977-06-21 1982-01-31 Rech Applications Therap Derivatives of amidinopenicillanic acid,their production and pharmaceutical compositions containing them
DE2963717D1 (en) * 1978-05-06 1982-11-04 Beecham Group Plc Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them
US4244965A (en) * 1978-06-15 1981-01-13 Beecham Group Limited Azetidinoyl ethers
US4252722A (en) * 1979-08-08 1981-02-24 Merck & Co., Inc. Process for the preparation of 6-hydroxymethyl-2-(β-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylic acid
US4237051A (en) * 1979-04-19 1980-12-02 Schering Corporation Stereospecific production of 6- or 7-carbon-substituted-β-lactams
US4231928A (en) * 1979-04-24 1980-11-04 Bristol-Myers Company Antibacterial agents

Also Published As

Publication number Publication date
US4438101A (en) 1984-03-20
DD126929A5 (es) 1977-08-24
DK457676A (da) 1977-04-14
SU639454A3 (ru) 1978-12-25
PT65707B (en) 1978-04-17
AT352874B (de) 1979-10-10
PT65707A (en) 1976-11-01
JPS5248686A (en) 1977-04-18
CH639665A5 (de) 1983-11-30
NL7611206A (nl) 1977-04-15
ATA753476A (de) 1979-03-15
ES452361A1 (es) 1978-01-01
AR213294A1 (es) 1979-01-15
SE8004329L (sv) 1980-06-10
ZM12276A1 (en) 1977-07-21
MX4688E (es) 1982-08-02
GB1566706A (en) 1980-05-08
BE847044A (fr) 1977-04-07
SE7611047L (sv) 1977-04-14
AU503489B2 (en) 1979-09-06
AU1858276A (en) 1978-04-20
JPS612670B2 (es) 1986-01-27
NO802661L (no) 1977-04-14
ZA765901B (en) 1977-09-28
US4382084A (en) 1983-05-03
CA1094563A (en) 1981-01-27
HU175046B (hu) 1980-05-28
DE2646003A1 (de) 1977-04-21
NZ182190A (en) 1979-03-16
FR2327775A1 (fr) 1977-05-13
NO763472L (es) 1977-04-14
NO802662L (no) 1977-04-14
CH634323A5 (de) 1983-01-31
IL50618A (en) 1979-09-30
FR2327775B1 (es) 1978-11-17
GR61674B (en) 1978-12-05
FI762895A (es) 1977-04-14
IL50618A0 (en) 1976-12-31
IE43840B1 (en) 1981-06-03
IE43840L (en) 1977-04-13
SE8004330L (sv) 1980-06-10
US4256638A (en) 1981-03-17

Similar Documents

Publication Publication Date Title
ES463974A1 (es) Un procedimiento para la preparacion de nuevos derivados delacido clavulanico.
ES469568A1 (es) Procedimiento para la obtencion de compuestos de acido 2-pe-nem-3-carboxilicos
ES459785A1 (es) Un procedimiento para la preparacion de nuevos esteres anti-bacterianos.
ES444948A1 (es) Un procedimiento para la separacion de impurezas contaminan-tes del acido clavulanico.
ES455404A1 (es) Un procedimiento para la preparacion de nuevos derivados de beta-lactama.
ES459261A1 (es) Un procedimiento para preparar derivados de cefalosporina.
ES454997A1 (es) Procedimiento para preparar nuevos derivados del acido 7- amino-tiazolil-acetamido-cefalosporanico.
ES8407053A1 (es) Un procedimiento para la preparacion de nuevos derivados de penem-2-tiosustituidos.
ES464123A1 (es) Un procedimiento para la preparacion de esteres de acido clavulanico.
ES471769A1 (es) Procedimiento para la obtencion de penicilinas
ES486026A1 (es) Un procedimiento para la preparacion de antibioticos de ce- falosporina
GB1493197A (en) Amides of clavulanic acid
GB2005246A (en) beta -Lactam compounds and processes for their preparation
ES8302093A1 (es) Un procedimiento para obtener nuevos compuestos de beta-lac-tama
ES461983A1 (es) Un procedimiento para la preparacion de nuevas cefalospori- nas.
ES8306377A1 (es) Un procedimiento para la preparacion de cefalosporina bis-tetrazolmetil sustituidas.
ES423024A1 (es) Procedimiento para la preparacion de derivados de acidos penicilanico y cefalosporanico.
GB1389195A (en) Antibiotics
ES449142A1 (es) Procedimiento para la obtencion de antibioticos de beta-lac-tama.
ES476259A1 (es) Un procedimiento para la preparacion de un compuesto.
PT74196B (en) Process for preparing ketohydroxyiminocephalosporins
JPS54154782A (en) Penicillin derivative and its salt
JPS5579394A (en) Novel 7-methoxycephalosporin derivative
ES452779A1 (es) Procedimiento para la obtencion de cefaloesporinas.
ES454104A1 (es) Un procedimiento para la preparacion de un acido 6-(d-2-aci-lamido-2-fenilacetamido) penicilanico.